|
|||||
|
|
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease. |
|
| Authors: | Daniel J DeAngelo Ephraim P Hochberg Edwin P Alyea Janina Longtine Stephanie Lee Ilene Galinsky Ben Parekkedon Jerome Ritz Joseph H Antin Richard M Stone Robert J Soiffer |
| Affiliation: | Dana-Farber Cancer Institute, Department of Adult Oncology, Boston, Massachusetts 02115, USA. |
| Abstract: | |
| Keywords: | |